“pcsk9” Archives

in
Entry Author Date Location
Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes 06/11/20 Boston
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B 11/25/19 New York
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing 09/02/19 New York
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.) 08/26/19 National
Bio Roundup: Pharma in DC, Bristol-Cel in Trouble, Roche Gets A Spark 03/01/19 National
15 For ’19: Key Clinical Data to Watch For Next Year (Part 2) 12/18/18 National
Regeneron to Slash Price of Cholesterol Drug After Showing It Saved Lives 03/10/18 New York
Esperion Touts Low Cholesterol Drug Price, But Not All Data are Ready 03/07/18 Detroit Ann Arbor
15 For ’18: Key Clinical Data to Watch For Next Year (Part 1) 12/04/17 National
Medicines Co. Sells Infectious Disease Drugs, Focusing on PCSK9 11/29/17 New York
Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing 09/11/17 New York
Will Merck Seek FDA Filing For Heart Drug After Lackluster Results? 08/29/17 New York
70% Repatha Cut? Amgen Counters With Own Study To Justify Price 08/23/17 National
Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More 08/11/17 National
The Medicines Co., Alnylam Take Plunge, Outline Big Test For Heart Drug 04/26/17 New York
FDA OKs Eczema Injection; Owners Regeneron, Sanofi Set $37K Price 03/28/17 New York
With New Data, Amgen Promises Refund If Cholesterol Drug Doesn’t Work 03/17/17 San Francisco
Often Advocates Of Faster FDA, Patient Groups Wary Of Trump Deregulation 02/10/17 National
Bio Roundup: Travel Ban, Pharma in DC, Biogen Splits, PCSK9 Wins 02/03/17 National
No Details Yet, But Amgen Touts Success in Big Heart Drug Study 02/02/17 San Francisco
Biotech Roundup: JPM Deals, Gender Diversity, PCSK9 Battle & More 01/13/17 National
14 For ’17: Key Clinical Data to Watch For Next Year (Part 1) 12/21/16 National
Arrowhead’s Future Could Now Ride on Progress of Amgen Partnership 11/30/16 Wisconsin
With New Data, Medicines Co. Takes Long-Lasting Heart Drug to Phase 3 11/15/16 New York
Bio Roundup: Clinical Shirkers, AMD Worriers, ASH Fallers & More 11/04/16 National
Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More 09/02/16 National
Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More 08/19/16 National
Struggling Aegerion, QLT to Merge, Change Name to Novelion 06/15/16 Boston
Advisory Panel Backs Intercept’s Liver Drug, FDA Ruling up Next 04/07/16 New York
Page 1 of 2 next page »